Related references
Note: Only part of the references are listed.Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo
Samah A. Eldelee et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study
Silada Kanokrungsee et al.
JOURNAL OF COSMETIC DERMATOLOGY (2021)
Associations of plasma 8-iso-prostaglandin F2α levels with fasting blood glucose (FBG) and intra-abdominal fat (IAF) area in various Glycometabolism populations
Ning Ma et al.
BMC ENDOCRINE DISORDERS (2021)
Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population
Nasrin Hamidizadeh et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Influence of smoking on levels of urinary 8-iso Prostaglandin F2α
Angela van der Plas et al.
TOXICOLOGY REPORTS (2019)
Silymarin: An interesting modality in dermatological therapeutics
Konchok Dorjay et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2018)
The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo
Nanja van Geel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo
John E. Harris
IMMUNOLOGICAL REVIEWS (2016)
Oxidative stress and ageing
M. A. Birch-Machin et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Vitiligo is not a cosmetic disease
Khaled Ezzedine et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
The effect of latanoprost on vitiligo: a preliminary comparative study
Tag S. Anbar et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation
Jochen Bauer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The Activity of 8-Iso-Prostaglandin F2α as an Oxidative Stress Marker In Vivo in Paediatric Patients with Type 1 Diabetes Mellitus and Associated Autoimmunities
Andreea Liana Rachisan et al.
CLINICAL LABORATORY (2014)
Prostaglandin F2 Alpha Plasma Concentration Predicts Glycemic Control and Oxidation Status in Patients with Type 2 Diabetes Mellitus
Manouchehr Nakhjavani et al.
CLINICAL LABORATORY (2014)
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Tobias Bald et al.
NATURE (2014)
Vitiligo, reactive oxygen species and T-cells
Steven J. Glassman
CLINICAL SCIENCE (2011)
Bioactive eicosanoids: Role of prostaglandin F2α and F2-isoprostanes in inflammation and oxidative stress related pathology
Samar Basu
MOLECULES AND CELLS (2010)
Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo
R. Kapoor et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-α Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells
Luigia Di Francesco et al.
CIRCULATION RESEARCH (2009)
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?
K. U. Schallreuter et al.
EXPERIMENTAL DERMATOLOGY (2008)
PGF2α-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN
K. M. Rice et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2008)
Parametric modeling of UV-B of narrowband phototherapy for vitiligo using a novel quantitative tool - The vitiligo area scoring index
I Hamzavi et al.
ARCHIVES OF DERMATOLOGY (2004)
Topical prostaglandin analog (PGE2) in vitiligo -: a preliminary study
D Parsad et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology
VA Ziboh et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Share Paper
